Author response to letter to the editor, "PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity"

Affiliations

• ¹ Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
• ² Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
• ³ Department of Rheumatology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Chuo-Ku, Hamamatsu, Shizuoka, 430-8558, Japan.
• ⁴ Kobayakawa Orthopaedics and Rheumatologic Clinic, 1969 Kuno, Fukuroi, Shizuoka, 437-0061, Japan.
• ⁵ Department of Orthopaedic Surgery, National Hospital Organization, Osaka Minami Medical Center, Kawachinagano, 586-8521, Japan.
• ⁶ Department of Orthopaedic Surgery, Osaka Rosai Hospital, Sakai, 591-8025, Japan.
• ⁷ Department of Orthopaedic Surgery, Nippon Medical School, Tokyo, 113-8603, Japan.
• ⁸ Department of Orthopaedic Surgery, Japan Community Health Care Organization (JCHO) Hoshigaoka Medical Center, Hirakata, 573-8511, Japan.
• ⁹ Department of Orthopaedic Surgery, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka 560-8552, Japan.
• ¹⁰ Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, 530-0021, Japan.
• ¹¹ Department of Health and Sport Sciences, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
• ¹² Department of Sports Medical Biomechanics, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. Electronic address: k-ebina@ort.med.osaka-u.ac.jp.